Original Article Pediatric Surgery Urology
Association between low-dose aspirin and falls: evidence from patients on haemodialysis

Association between low-dose aspirin and falls: evidence from patients on haemodialysis

Authors

Lucas Zhang

Lucas Zhang

Mayo Clinic, Brazil

Corresponding
Yusuf Rossi

Yusuf Rossi

Mayo Clinic, Puerto Rico

Lucas Nasser

Lucas Nasser

King Fahad Medical City, Kyrgyzstan

Published

January 30, 2026

Paper ID

PAP-000118

Status

Published

DOI

10.65712/tmj.test000376

Association between low-dose aspirin and falls: evidence from patients on haemodialysis

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: Earlier studies of low-dose aspirin were small or single-centre. Methods: Analyses were adjusted for age, sex and baseline severity. Results: Serious adverse events were rare and similar between groups. Serious adverse events were rare and similar between groups. Conclusion: Future work should test low-dose aspirin in a pragmatic multicentre trial.

Introduction

Guidelines make only a weak recommendation on low-dose aspirin.

The cost of falls to health systems is substantial. falls remains a leading cause of avoidable harm among patients on haemodialysis.

Guidelines make only a weak recommendation on low-dose aspirin. Practice around low-dose aspirin varies widely between centres. Earlier studies of low-dose aspirin were small or single-centre.

The cost of falls to health systems is substantial. Earlier studies of low-dose aspirin were small or single-centre.

Materials and Methods

Missing data were handled with multiple imputation.

We conducted a cross-sectional survey across 10 centres between 2014 and 2024. Analyses were adjusted for age, sex and baseline severity.

Results

Effects were consistent across prespecified subgroups. falls occurred in 21% of the intervention group versus 29% of controls.

The adjusted odds ratio was 0.79 (95% CI 0.30 to 0.78). Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups.

GroupnEventsRate %OR
Centre A6668229.00.50
Age < 6523110934.30.97
Control36311436.40.52
Centre A1932315.90.50
Age ≥ 6525611518.00.70
TABLE 1: Primary outcome by group
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Forest plot of falls
Shown for patients on haemodialysis; error bars are 95% confidence intervals.
Figure 2
FIGURE 2: Kaplan–Meier curve for falls
Shown for patients on haemodialysis; error bars are 95% confidence intervals.

1867 participants were included (median age 68 years). falls occurred in 7% of the intervention group versus 32% of controls. The adjusted odds ratio was 0.44 (95% CI 0.28 to 0.92). 1597 participants were included (median age 67 years).

Effects were consistent across prespecified subgroups. 1207 participants were included (median age 40 years). 3045 participants were included (median age 67 years).

Discussion

Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment.

Residual confounding cannot be excluded. Future work should test low-dose aspirin in a pragmatic multicentre trial.

Future work should test low-dose aspirin in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment.

Strengths include the sample size and blinded outcome assessment. Future work should test low-dose aspirin in a pragmatic multicentre trial. Residual confounding cannot be excluded.

Implementation will depend on staffing, cost and local protocols. These findings suggest that low-dose aspirin is associated with better falls in patients on haemodialysis.

Conclusions

Low-dose aspirin merits wider use for patients on haemodialysis to improve falls.

References

1. Larsen F, Yilmaz L, et al. Delayed cord clamping and health-related quality of life. Pediatrics. 2015;81(8):427-1115.

2. Ibrahim V, Silva J, et al. Home-based cardiac rehabilitation and falls. N Engl J Med. 2012;297(9):675-1261.

3. Zhang Q, Silva H, et al. Early enteral nutrition and post-operative delirium. Eur Heart J. 2017;198(3):224-1175.

4. Yilmaz G, Novak I, et al. Vitamin D supplementation and in-hospital mortality. BMJ. 2022;27(12):644-936.

5. Costa J, Rossi R, et al. A sepsis alert system and post-operative delirium. BMJ. 2010;365(10):760-1014.

6. Nasser P, Tanaka Y, et al. SGLT2 inhibitors and length of stay. N Engl J Med. 2009;163(7):38-910.

7. Nasser C, Mensah L, et al. Low-dose aspirin and medication adherence. Crit Care Med. 2009;173(10):520-933.

8. Patel D, Dubois I, et al. Point-of-care ultrasound and health-related quality of life. N Engl J Med. 2012;105(7):775-1014.

Appendices

Supplementary tables are available on request.